Cargill’s erythritol dental health claim rejected by EFSA

791f45fc-913c-4cfa-a947-038ec3c1fdb0articleimage.jpg

27 Jul 2017 --- Cargill cannot prove its EU Article 14 claim submission [disease risk reduction claim] that there is a cause-and-effect relationship between sugar-free hard confectionery with at least 90 percent erythritol and the reduction of dental plaque, according to the European Food Safety Authority (EFSA).

Cargill had applied to be able to legally make a claim on its confectionery. As a rule: “health claims are prohibited unless they comply with the general and specific requirements of Regulation (EC) No 1924/2006, which establishes rules governing the European Community authorization of health claims made on foods,” EFSA says.

Cargill wanted to make the following claim possible on confectionery products sweetened with erythritol: “Sugar-free hard confectionery sweetened with at least 90 percent Zerose erythritol has been shown to reduce dental plaque. High content/level of dental plaque is a risk factor in the development of caries.”

The company had therefore submitted a dossier to EFSA aiming to prove that the effect of erythritol: “could be explained by a reduction in dental plaque resulting from reduced growth and adherence of common streptococcal oral bacteria to tooth surfaces and reduced acid production by the bacteria.”

However, EFSA experts say they could not substantiate the claim “in the absence of evidence for an effect on the incidence of dental caries in vivo in humans.”

A large issue with the claim was the fact that Cargill did not specify which properties of Zerose erythritol sugar-free hard confectionery were “unique in relation to the claimed effect as compared to other sugar-free hard confectionery containing 90 percent erythritol.” EFSA experts, therefore, decided that Cargill could not make a claim unique to its product.

Problems with one of the studies that Cargill used were also pointed out by EFSA scientists: “In weighing the evidence, the Panel took into account that one human intervention study […] with some methodological limitations (e.g. data analysis for completers only) did not show an effect of sugar-free hard confectionery with at least 90 percent erythritol on the incidence of dental caries in children on either mixed or permanent dentition.”

The food constituent Zerose erythritol, the subject of the claim, “is a low molecular weight polyol that has zero calories and is non-glycaemic and non-insulinemic,” according to the EFSA report. “The erythritol is in the form of sugar-free hard confectionery sweetened with at least 90 percent Zerose erythritol.” 

Sugar-free hard confectionery is classified by EFSA as candies with a hard texture with no added sugar, and sugar-free hard confectionery includes hard candies, pastilles, lozenges, tablets and breath-freshening micro sweets. 

The full opinion of EFSA from its journal can be read here.

By Paul Creasy

Related Articles

Nutrition & Health News

AI: Nuritas explores potential health benefits during Future of Nutrition Summit

13 Dec 2017 --- Biotechnology company Nuritas has innovative plans for using artificial intelligence (AI) to relieve the potential burden of future global health issues. These plans were outlined during its Future of Nutrition Summit held the day before FiE 2017 in Frankfurt, during which Nuritas Commercial Manager Neil Foster outlined the company’s use of AI for data mining for bioactive peptides, specific molecules with “tremendous” health benefits.

Business News

Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 --- One of the major issues to be discussed at Vitafoods Europe 2018 will be how personalized nutrition can break out of its niche and achieve mass market appeal, the organizers of the global nutraceutical event have announced. Advances in genomics and wearable technology have created new opportunities for products tailored to individual consumers. And in a new poll conducted by the organizers, personalized nutrition ranks as one of the most important industry trends for 2018, behind only clean label and scientifically supported health claims.

Business News

Kappa Bioscience moves to expand vitamin K2 presence in US with new appointments

13 Dec 2017 --- Kappa Bioscience AS, maker of K2Vital vitamin K2 MK-7, has appointed Garnet Pigden and New Jersey-based D2C to head-up the continued development of Kappa’s position in the US market. The appointment spans the establishment of strategy, infrastructure, partnerships and key accounts in support of an overall objective of solidifying vitamin K2 in mainstream US markets and channels, according to Kappa.

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Business News

Kappa Bioscience reveals free vitamin K2 MK-7 quality testing program

06 Dec 2017 --- Kappa Bioscience has announced the worldwide launch of a free vitamin K2 MK-7 quality testing program. The program, announced at CPhI India, is open to finished K2 products, from any source, for testing and verification of the product’s K2 label claim. The program supports wider goals of educating markets about K2 stability and advancing K2 science to resolve the question of why unprotected K2 is unstable in mineral formulations. 

More Articles
URL : http://www.nutritioninsight.com:80/news/cargills-erythritol-dental-health-claim-rejected-by-efsa.html